Shares in Serono lost 8% this morning amid reports that potential buyers had failed to submit bids by a Friday deadline set by Goldman Sachs, which is running the Swiss biotechnology company's auction.

Serono hired Goldman last year to find a buyer for the Bertarelli family's 62% stake, handing the investment bank its first mergers and acquisitions mandate for the company.